Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment
NCT ID: NCT06400173
Last Updated: 2024-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
450 participants
OBSERVATIONAL
2023-09-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder
NCT03581643
Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
NCT07297121
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
NCT03246269
Advances in Telephone-based Cognitive Screening Procedures
NCT06337578
Evaluating an In-home Multicomponent Program to Manage Concerns About Falling in Frail Community Dwelling Older People
NCT01358032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals (>45 years) with mild cognitive impairment and hearing loss
All tests will be administered.
Cognitive screening
The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.
Audiological Assessment
Four audiological tests are included in the audiological assessment
1. Tympanometry to assss the middle ear status
2. Pure-tone audiometry with headphone to evaluate the hearing thresholds
3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise
4. The hAVICOP questionnaire to assess the hearing-related quality of life
Individuals (>45 years) with dementia (Alzheimer, vascular or mixed) and hearing loss
All tests will be administered.
Cognitive screening
The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.
Audiological Assessment
Four audiological tests are included in the audiological assessment
1. Tympanometry to assss the middle ear status
2. Pure-tone audiometry with headphone to evaluate the hearing thresholds
3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise
4. The hAVICOP questionnaire to assess the hearing-related quality of life
Individuals (>45 years) with age-normal cognition and hearing loss
All tests will be administered.
Cognitive screening
The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.
Audiological Assessment
Four audiological tests are included in the audiological assessment
1. Tympanometry to assss the middle ear status
2. Pure-tone audiometry with headphone to evaluate the hearing thresholds
3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise
4. The hAVICOP questionnaire to assess the hearing-related quality of life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive screening
The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.
Audiological Assessment
Four audiological tests are included in the audiological assessment
1. Tympanometry to assss the middle ear status
2. Pure-tone audiometry with headphone to evaluate the hearing thresholds
3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise
4. The hAVICOP questionnaire to assess the hearing-related quality of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals with normal vision (with lenses or glasses if needed)
* Individuals with age-related hearing loss
* Dutch-speaking individuals
* Individuals capable of giving consent to participate in the study themselves
* Individuals still residing in their own homes
* Individuals with an official diagnosis of dementia (Alzheimer's, vascular, or mixed) or mild cognitive impairment. This inclusion criterion applies only to the group with cognitive impairment.
Exclusion Criteria
* Use of influencing medication (e.g., Ritalin and antidepressants)
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tim Van Langenhove, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Ghent Hospital
Ghent, East-Flanders, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2023-0147
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.